OralKleen, Inc. — SEC Form D Filing

OralKleen, Inc. filed an SEC Form D on September 17, 2026, reporting $300K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
September 17, 2026
Amount reported
$300K
Round stage
Seed
Industry
Medical Devices
Website
https://oralkleen.com/

What the company does

Securities: Equity, SAFE (Simple Agreement for Future Equity) and shares of capital stock to be issued on conversion of SAFE.. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Intubated patients and those dependent on others for oral care often experience significantly worse oral health outcomes and are at high risk of developing ventilator-associated pneumonia (VAP), which has a high mortality rate. Standard oral care methods are often inadequate in preventing these issues.

Solution

OralKleen provides a comprehensive oral care system including specialized toothpaste, mouth gel, lip balm, and an electric toothbrush with integrated suction and lighting, along with other tools like a scraper and swab stick. This system is designed to improve oral health, reduce VAP rates, and streamline oral care for patients at risk for healthcare-associated pneumonia.

Why now

There is a growing awareness of the critical link between oral hygiene and overall patient health, particularly in preventing healthcare-associated infections like VAP. Advances in medical technology allow for more effective and efficient oral care solutions in clinical settings.

Verdict

This cleared because it offered a tangible solution to a high-cost clinical problem, ventilator-associated pneumonia (VAP), rather than solely relying on general "preventative health" trends. Investors were implicitly betting that a device-plus-consumables model could penetrate established hospital procurement channels and dislodge entrenched, albeit less effective, standard care practices. This narrative limited upside by focusing heavily on VAP, potentially narrowing initial market perception and making broader oral care applications secondary in the investment thesis.

Source: SEC EDGAR Form D filing